In silico identification of transcriptional regulators associated with c-Myc.

The development of powerful experimental strategies for functional genomics and accompanying computational tools has brought major advances in the delineation of transcriptional networks in organisms ranging from yeast to human. Regulation of transcription of eukaryotic genes is to a large extent combinatorial. Here, we used an in silico approach to identify transcription factors (TFs) that form recurring regulatory modules with c-Myc, a protein encoded by an oncogene that is frequently disregulated in human malignancies. A recent study identified, on a genomic scale, human genes whose promoters are bound by c-Myc and its heterodimer partner Max in Burkitt's lymphoma cells. Using computational methods, we identified nine TFs whose binding-site signatures are highly overrepresented in this promoter set of c-Myc targets, pointing to possible functional links between these TFs and c-Myc. Binding sites of most of these TFs are also enriched on the set of mouse homolog promoters, suggesting functional conservation. Among the enriched TFs, there are several regulators known to control cell cycle progression. Another TF in this set, EGR-1, is rapidly activated by numerous stress challenges and plays a central role in angiogenesis. Experimental investigation confirmed that c-Myc and EGR-1 bind together on several target promoters. The approach applied here is general and demonstrates how computational analysis of functional genomics experiments can identify novel modules in complex networks of transcriptional regulation.

[1]  G. Church,et al.  Systematic determination of genetic network architecture , 1999, Nature Genetics.

[2]  M. Cole,et al.  The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation , 1999, Oncogene.

[3]  E. Winzeler,et al.  Genomics, gene expression and DNA arrays , 2000, Nature.

[4]  John J. Wyrick,et al.  Genome-wide location and function of DNA binding proteins. , 2000, Science.

[5]  G. Church,et al.  Identifying regulatory networks by combinatorial analysis of promoter elements , 2001, Nature Genetics.

[6]  L. Penn,et al.  Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. , 2001, Journal of cell science.

[7]  L. Penn,et al.  Mechanism for the transcriptional repression by c-Myc on PDGF (β)-receptor , 2001 .

[8]  M E Greenberg,et al.  Myc requires distinct E2F activities to induce S phase and apoptosis. , 2001, Molecular cell.

[9]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[10]  Stella Pelengaris,et al.  c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.

[11]  Nicola J. Rinaldi,et al.  Transcriptional Regulatory Networks in Saccharomyces cerevisiae , 2002, Science.

[12]  John L Cleveland,et al.  c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. , 2002, Genes & development.

[13]  Giuseppe Cibelli,et al.  Regulation of life and death by the zinc finger transcription factor Egr‐1 , 2002, Journal of cellular physiology.

[14]  G. Church,et al.  Genome-wide co-occurrence of promoter elements reveals a cis-regulatory cassette of rRNA transcription motifs in Saccharomyces cerevisiae. , 2002, Genome research.

[15]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[16]  J. Bartek,et al.  E2F activity is essential for survival of Myc-overexpressing human cancer cells , 2002, Oncogene.

[17]  L. Penn,et al.  The myc oncogene: MarvelouslY Complex. , 2002, Advances in cancer research.

[18]  M. Roussel,et al.  Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. , 2003, Molecular cell.

[19]  Kathryn A. O’Donnell,et al.  An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets , 2003, Genome Biology.

[20]  R. Sharan,et al.  Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. , 2003, Genome research.

[21]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[22]  Mark Gerstein,et al.  Distribution of NF-kappaB-binding sites across human chromosome 22. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. L. La Thangue,et al.  E2F and cell cycle control: a double-edged sword. , 2003, Archives of biochemistry and biophysics.

[24]  Thomas E. Royce,et al.  Distribution of NF-κB-binding sites across human chromosome 22 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Gartel,et al.  Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. , 2003, Experimental cell research.

[26]  D. Pe’er,et al.  Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data , 2003, Nature Genetics.

[27]  Levon M Khachigian,et al.  Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth , 2003, Nature Medicine.

[28]  John L Cleveland,et al.  Myc pathways provoking cell suicide and cancer , 2003, Oncogene.

[29]  Michael Q. Zhang,et al.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Daphne Koller,et al.  Genome-wide discovery of transcriptional modules from DNA sequence and gene expression , 2003, ISMB.

[31]  John D. Watson,et al.  Promoter-binding and repression of PDGFRB by c-Myc are separable activities. , 2004, Nucleic acids research.

[32]  Simon C. Potter,et al.  An overview of Ensembl. , 2004, Genome research.

[33]  E. Birney,et al.  EnsMart: a generic system for fast and flexible access to biological data. , 2003, Genome research.